During the November 2017 public consultation to solicit input on regulations under the Cannabis Act, it was determined that further consideration was necessary in order to determine an appropriate regulatory approach for health products containing cannabis without requiring the oversight of a medicinal practitioner. Under current regulatory framework already established by the Cannabis Act and
Proposed Approach to the Regulation of Health Products Containing Cannabis not Requiring Practitioner Oversight
